FDA Grants Mesoblast's Revascor Regenerative Medicine Advanced Therapy Designation In Children With Congenital Heart Disease
Merus Announces FDA Approval Of BIZENGRI For NRG1+ Pancreatic Adenocarcinoma And NRG1+ Non–Small Cell Lung Cancer Based On Safety And Efficacy Data From The ENRGy Study
Corvus Pharmaceuticals Announces Publication Of Biochemistry And Preclinical Data In "Nature" Demonstrating Potential Of ITK Inhibition With Soquelitinib As A Novel Approach To Modulate Tumor Immunity
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
FDA Grants Accelerated Approval To Zenocutuzumab-zbco For Non-Small Cell Lung Cancer And Pancreatic Adenocarcinoma
After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study